MX2024010596A - Composiciones que comprenden 5-metoxi-2-aminoindano (meai) y n-aciletanolaminas y usos de las mismas - Google Patents
Composiciones que comprenden 5-metoxi-2-aminoindano (meai) y n-aciletanolaminas y usos de las mismasInfo
- Publication number
- MX2024010596A MX2024010596A MX2024010596A MX2024010596A MX2024010596A MX 2024010596 A MX2024010596 A MX 2024010596A MX 2024010596 A MX2024010596 A MX 2024010596A MX 2024010596 A MX2024010596 A MX 2024010596A MX 2024010596 A MX2024010596 A MX 2024010596A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methoxy
- acylethanolamines
- meai
- aminoindane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263317257P | 2022-03-07 | 2022-03-07 | |
| PCT/IB2023/052091 WO2023170552A1 (en) | 2022-03-07 | 2023-03-06 | Compositions comprising meai and n-acylethanolamines and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024010596A true MX2024010596A (es) | 2025-01-09 |
Family
ID=85706794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024010596A MX2024010596A (es) | 2022-03-07 | 2024-08-29 | Composiciones que comprenden 5-metoxi-2-aminoindano (meai) y n-aciletanolaminas y usos de las mismas |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250302773A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4489741A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025508052A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119212690A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023231494A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3244360A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL315486A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024010596A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023170552A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024062395A1 (en) * | 2022-09-21 | 2024-03-28 | Clearmind Medicine Inc. | Use of 5-methoxy-2-aminoindan ("meai") in methods for treating metabolic syndrome |
| WO2025196662A1 (en) * | 2024-03-20 | 2025-09-25 | Clearmind Labs Corp. | Compositions and methods for treating eating disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114946A (en) | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
| US4818541A (en) | 1987-08-19 | 1989-04-04 | Schering Corporation | Transdermal delivery of enantiomers of phenylpropanolamine |
| ES2139750T3 (es) | 1993-08-06 | 2000-02-16 | Upjohn Co | 2-aminoindanos como ligandos selectivos d3 de la dopamina. |
| WO2005002524A2 (en) * | 2003-07-02 | 2005-01-13 | The Regents Of The University Of California | COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES OF OLEOYLETHANOLAMIDE-LIKE COMPOUNDS AND MODULATORS OF PPARα |
| WO2016092546A1 (en) * | 2014-12-09 | 2016-06-16 | Ezekiel Golan | Binge behavior regulators |
| ES2580508B1 (es) * | 2016-04-11 | 2018-09-12 | Servicio Andaluz De Salud | Composiciones para la prevención y/o tratamiento de los trastornos por uso de alcohol. |
-
2023
- 2023-03-06 CN CN202380038816.0A patent/CN119212690A/zh active Pending
- 2023-03-06 EP EP23712345.0A patent/EP4489741A1/en active Pending
- 2023-03-06 CA CA3244360A patent/CA3244360A1/en active Pending
- 2023-03-06 US US18/844,341 patent/US20250302773A1/en active Pending
- 2023-03-06 AU AU2023231494A patent/AU2023231494A1/en active Pending
- 2023-03-06 JP JP2024553359A patent/JP2025508052A/ja active Pending
- 2023-03-06 IL IL315486A patent/IL315486A/en unknown
- 2023-03-06 WO PCT/IB2023/052091 patent/WO2023170552A1/en not_active Ceased
-
2024
- 2024-08-29 MX MX2024010596A patent/MX2024010596A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3244360A1 (en) | 2023-09-14 |
| WO2023170552A1 (en) | 2023-09-14 |
| US20250302773A1 (en) | 2025-10-02 |
| IL315486A (en) | 2024-11-01 |
| CN119212690A (zh) | 2024-12-27 |
| EP4489741A1 (en) | 2025-01-15 |
| JP2025508052A (ja) | 2025-03-21 |
| AU2023231494A1 (en) | 2024-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4506001A3 (en) | SUBSTITUTED TETRAHYDROFURANS AS SODIUM CHANNEL MODULATORS | |
| CR20220082A (es) | N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos | |
| MX2020010999A (es) | Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos. | |
| MX2020007625A (es) | Inhibidor mtor, composicion farmaceutica y su uso. | |
| BR112017026159A2 (pt) | inibidores heterocíclicos de erk1 e erk2 e seu uso no tratamento de câncer | |
| BR112015029512A8 (pt) | derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas | |
| MX2020005518A (es) | Mezclas no racemicas y usos de las mismas. | |
| BR112023018472A2 (pt) | Composições de psilocibina, métodos de produção e métodos de uso das mesmas | |
| AR117655A1 (es) | Composición farmacéutica para administración oral que comprende derivado de aminopirimidina o su sal | |
| HRP20230300T1 (hr) | Kombinacije imetelstata i venetoklaksa za liječenje akutne mijeloidne leukemije | |
| MX2024000828A (es) | Formulaciones de parasiticida de isoxazolina y metodos para el tratamiento de la blefaritis. | |
| BR112021025701A2 (pt) | Formulações e métodos de parasiticida de isoxazolina para tratar blefarite | |
| EA201071043A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1 | |
| MX2021014774A (es) | Formulaciones de liberacion modificada y usos de las mismas. | |
| SA523440574B1 (ar) | مثبطات إنترليوكين-17 | |
| MX2023006235A (es) | Composiciones para administracion de farmacos y metodos de uso de las mismas. | |
| BR112019018615A2 (pt) | compostos antimicrobianos, composições e usos dos mesmos | |
| MX384072B (es) | Compuesto derivado de pirrolo-piridina, metodo para preparar el mismo y composicion farmaceutica que contiene el mismo como ingrediente activo para la prevencion o el tratamiento de enfermedades relacionadas con la proteina cinasa. | |
| CL2023002698A1 (es) | Inhibidores de integrina alpha v beta 6 y alpha v beta 1 y sus usos | |
| MX2022006742A (es) | Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter. | |
| GB2590189A9 (en) | Lycorine derivatives, pharmaceutical composite thereof and usage therefor | |
| BR112022005736A2 (pt) | Compostos de azaindol carboxamida para o tratamento de infecções micobacterianas | |
| WO2019004788A3 (ko) | 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물 | |
| JOP20230275A1 (ar) | معدلات trex1 | |
| BR112022009881A2 (pt) | Inibidores de caspase 6 e usos dos mesmos |